Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
IGCIGC Pharma, Inc.
| Figure | IGCIGC Pharma, Inc.FY2025 · Mar |
|---|---|
| Revenue | $1.27M |
| Revenue, yoy | −5.5% |
| Net income | $7.12M |
| Net income, yoy | +45.2% |
| Net margin | -560.3% |
| Free cash flow | $4.91M |
| FCF margin | -386.1% |
| EPS, diluted | $0.09 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed